SIFCO Industries (NYSEAM) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
5 Oct, 2026Executive summary
Virtual annual meeting scheduled for Jan. 29, 2025; shareholders will vote on four director nominees and ratification of RSM US LLP for FY2025.
Record date Dec. 3, 2024; proxy materials cover FY ended Sept. 30, 2024.
Voting matters and shareholder proposals
Board recommends FOR all four one-year director nominees and FOR RSM US LLP; auditor ratification is non-binding and requires a majority of shares present and voting.
Each common share carries one vote; 6,170,051 shares were outstanding on the record date, and a majority present in person or by proxy constitutes a quorum.
Proposals for inclusion in the 2026 proxy materials are due Aug. 25, 2025; other proposals must be delivered by Oct. 30, 2025.
Board of directors and corporate governance
Four nominees are Robert D. Johnson, Donald C. Molten Jr., Alayne L. Reitman and Mark J. Silk; each would serve until the 2026 annual meeting.
The Board held 15 meetings in FY2024; every director attended at least 75% of Board and applicable committee meetings, and all attended the 2024 annual meeting.
Standing committees comprise independent directors; Reitman chairs the Audit Committee and Board, with the chair/CEO roles separated since Jan. 31, 2023.
Nominee reviews consider experience, skills and viewpoint diversity; shareholders may submit candidate recommendations in writing to the Nominating and Governance Committee or Corporate Secretary.
Latest events from SIFCO Industries
- FY24 sales rose 20%, with $114.4M backlog driving increased production.NYSEAM
Q4 2024 - Sales rose 6%, continuing losses narrowed, and year-end backlog reached $119.2m.NYSEAM
Q4 2025 - H1 sales rose 10.9%, losses narrowed, and backlog reached $129.2M.NYSEAM
Q2 2025 - Q3 growth lifted earnings, but October debt maturity leaves refinancing risk unresolved.NYSEAM
Q3 2024 - Higher military volumes and pricing drove a sharp return to profit, with financing and environmental risks persisting.NYSEAM
Q2 2026 - Sales rose 35.0%, losses narrowed, and backlog reached $121.9M.NYSEAM
Q1 2025 - ERC benefits and aerospace demand lifted Q3 profit; backlog stood at $130.4M.NYSEAM
Q3 2025 - Military demand lifted nine-month results and backlog, while Q3 earnings absorbed a $3.2 million LIFO impact.NYSEAM
Q3 2026 - Sales rose 14.8% as military demand drove a return to profit and backlog growth.NYSEAM
Q1 2026